RSS

Series A financing round

Antiviral drug discovery and development company, ReViral, has successfully completed its Series B financing round, raising $55 million in funding. more

News

Antabio — a biopharma specialising in the development of novel antibacterial treatments — has extended its Series A financing round with an additional €5.2 million from new investors to add to the €7.3 million raised in the first closing last year. more

News

Aptamer Group — a biotech business — has closed its Series A financing round, securing $2.2 million from overseas investors to support its aptamer development programme. more

News